Live Watch CBSN Live There's a growing number of cases of the Multisystem Inflammatory Syndrome in Children, sometimes called Pediatric Multisystem Inflammatory Syndrome, affecting children. Now, doctors say they are seeing the illness in teens and young adults. Chip Reid has the latest.
Four children in Los Angeles County diagnosed with a rare inflammatory disease have tested positive for COVID-19 through antibody testing, officials said Monday.The county is investigating an additional 21 possible cases of the multisystem inflammatory syndrome associated with the illness, County Public Health Director Barbara Ferrer said. The nearly two dozen cases have been identified…
New York City health officials have identified 30 additional kids with pediatric multi-system inflammatory syndrome, a potentially fatal illness doctors suspect is being caused by Covid-19 infections.There are now 82 confirmed cases of PMIS in the city, up from 52 the day before, Mayor Bill de Blasio said at a press briefing Wednesday. Doctors are…
Dr. Oxiris Barbot attends Mayor bill de Blasio briefing on first registered community transfer covid-19 patient in New York at City Hall.Lev Radin | Pacific Press | Getty ImagesCoronavirus inflammatory syndrome in children is causing heart and kidney failure, New York City's top health official said Monday."This is something that is incredibly concerning," Health Commissioner Dr. Oxiris Barbot…
Robert F. Kennedy Jr. has rightly made “radical transparency” the motto of his Department of Health and Human Services. HHS even has a page by that name. I think it is a good motto, and I want to help Secretary Kennedy and Acting FDA Commissioner Kyle Diamantas deliver on it in food safety, with two citizen petitions
Published: October 30, 2026, 10:16 pm Several reports of children choking have led to an FDA warning against Once Upon A Time snacks. The warning covers all flavors, quantities, lots and dates of Once Upon A Farm Tractor Wheels Organic, Toddler Soft-Baked Bars. The FDA has received several reports that describe infants ages 1.5 to
The FDA has cleared the interleukin (IL)-23 inhibitor tildrakizumab (Ilumya) for the treatment of active psoriatic arthritis (PsA) in adults. Sun Pharma announced the approval on October 30. “As an IL-23 inhibitor administered exclusively by a healthcare provider, Ilumya is now an option for adults with active psoriatic arthritis who are unable to self-administer treatment